{{Rsnum
|rsid=2269529
|Gene=MYH9
|Chromosome=22
|position=36288308
|Orientation=plus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.2847
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MIR6819,MYH9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 24.8 | 69.9
| HCB | 33.8 | 46.3 | 19.9
| JPT | 43.4 | 42.5 | 14.2
| YRI | 0.0 | 4.8 | 95.2
| ASW | 0.0 | 15.8 | 84.2
| CHB | 33.8 | 46.3 | 19.9
| CHD | 44.0 | 38.5 | 17.4
| GIH | 27.7 | 46.5 | 25.7
| LWK | 0.9 | 21.8 | 77.3
| MEX | 10.3 | 29.3 | 60.3
| MKK | 0.6 | 16.0 | 83.3
| TSI | 6.9 | 40.2 | 52.9
| HapMapRevision=28
}}

{{Venter SNP
|rsid=2269529
|allele=C
|frequency=0
|uid=1103691039325
|type=heterozygous_SNP
|hugo=MYH9
|ensembl gene=ENSG00000100345
|ensembl transcript=ENST00000216181
|sift=TOLERATED
|disease=Defects in MYH9 are the cause of autosomal dominant nonsyndromic sensorineural deafness 17 (DFNA17) (MIM:603622). DFNA17 is characterized by progressive hearing impairment and cochleosaccular degeneration.
}}

{{PMID Auto
|PMID=19891592
|Title=Association Among Polymorphisms at MYH9, Environmental Factors, and Nonsyndromic Orofacial Clefts in Western China
}}

{{ClinVar
|rsid=2269529
|Reversed=0
|FwdREF=T
|FwdALT=C
|REF=T
|ALT=C
|RSPOS=36684354
|CHROM=22
|GMAF=0.2843
|dbSNPBuildID=100
|SSR=0
|SAO=1
|VP=0x050368000000150517100101
|GENEINFO=MYH9:4627
|GENE_NAME=MYH9
|GENE_ID=4627
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000022.10:g.36684354T>C
|CLNORIGIN=0
|CLNSIG=2
|Tags=PM;PMC;S3D;SLO;VLD;G5;HD;GNO;KGPhase1;KGPROD;OTHERKG;PH3;LSD
|CAF=0.7153; 0.2847
|CLNACC=RCV000032225.1; RCV000037563.1
|CLNDBN=MYH9 related disorders; AllHighlyPenetrant
|CLNDSDB=GeneReviews:MedGen; MedGen
|CLNDSDBID=NBK2689:CN073381; CN169374
|CLNSRC=GeneReviews
|CLNSRCID=NBK2689
|COMMON=1
|Disease=MYH9 related disorders; AllHighlyPenetrant
}}

{{PMID Auto
|PMID=18716610
|Title=Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate.
|OA=1
}}

{{PMID Auto
|PMID=20124285
|Title=Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
|OA=1
}}

{{GET Evidence
|gene=MYH9
|aa_change=Ile1626Val
|aa_change_short=I1626V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2269529
|overall_frequency_n=1647
|overall_frequency_d=10758
|overall_frequency=0.153095
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=24
|n_articles=0
|n_articles_annotated=0
|qualityscore_in_silico=1
|qualitycomment_in_silico=Y
|gene_in_genetests=Y
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=-4
|autoscore=3
|n_web_uneval=10
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}